ECAT insider reports sales at $16.55–$16.64, SEC filing
BlackRock ESG Capital Allocation Term Trust (ECAT) reported insider activity from a 10% owner.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock ESG Capital Allocation Term Trust (ECAT) reported insider activity from a 10% owner. Saba Capital Management, L.P. filed a Form 4 showing open-market sales of ECAT common stock. The filing lists 1,200 shares sold at $16.64 on October 28, 2025 and 75,953 shares sold at $16.55 on October 29, 2025. Following these transactions, Saba reported 27,400,370 shares beneficially owned, held indirectly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 75,953 | $16.55 | $1.26M |
| Sale | Common Stock | 1,200 | $16.64 | $20K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ECAT (BlackRock ESG Capital Allocation Term Trust) disclose in this Form 4?
What is the reported beneficial ownership after these transactions?
Was the ownership reported as direct or indirect?
Who signed the Form 4 for the reporting person?
What is the relationship of the reporting person to ECAT?
AI-generated analysis. How Rhea-AI works. Not financial advice.